The NUCaCD study aims to develop a reliable registry of patients suffering inflammatory bowel diseases in the Republic of Kazakhstan.
The NUCaCD aims to study the prevalence of inflammatory bowel diseases in the Republic of Kazakhstan and create a reliable database, which will greatly facilitate future planning of the volume of health resources needed to address these diseases management and will help to optimize preventive measures and will support future research to better understand the etiology, new options treatment and factors affecting prognosis, relapses, development of complications and quality of life.
Study Type
OBSERVATIONAL
Enrollment
2,000
Non-interventional study
Primary Health Clinic #5
Almaty, Kazakhstan
RECRUITINGTo study the incidence of NUC and CD in the Republic of Kazakhstan
To study the incidence of NUC and CD in the Republic of Kazakhstan
Time frame: 2 years
To study the patterns of the course of the disease and the treatment effect
To study the patterns of the course of the disease and the effectiveness of drug therapy in outpatient and inpatient clinics.
Time frame: 2 years
Conduct an analysis of the completeness of the diagnosis and compliance with the national guidelines for the diagnosis and treatment of ulcerative colitis and Crohn's disease
Conduct an analysis of the completeness of the diagnosis and compliance with the national guidelines for the diagnosis and treatment of ulcerative colitis and Crohn's disease
Time frame: 2 years
Analysis of the relationship between management strategies and treatment outcomes
Analysis of the relationship between management strategies and treatment outcomes
Time frame: 2 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.